Portfolio company
Phage therapy treatment
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops personalised bacteriophage cocktails and diagnostic susceptibility tests for patients suffering from multidrug-resistant bacterial infections.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Phaxiam
The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.
PRECISIONPHAGE
This company provides bacteriophage bioinformatics software and laboratory services for researchers, phage producers, and the healthcare industry to combat antimicrobial resistance.
Phagos
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
Phico Therapeutics
Phico Therapeutics develops engineered bacteriophage technology to treat multi-drug resistant bacterial infections in hospital patients.
MEDEA
This company develops bacteriophage-based antimicrobial products for customers in the human health, animal welfare, aquaculture and food protection sectors.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Locus Biosciences
This biotechnology company develops engineered bacteriophage therapies for patients with drug-resistant bacterial infections using CRISPR technology and artificial intelligence.
Felix Biotech
Felix Biotechnology develops engineered bacteriophage therapies to treat drug-resistant bacterial infections for patients with chronic diseases and partners in the skin care industry.
